Liz was appointed as an Independent Non-Executive Director on 1 September 2022.
Liz brings significant experience in commercial biopharmaceuticals and is a seasoned biotech board member. Her significant experience in commercial biopharmaceuticals, both operationally and at Board level, as well as her deep understanding of the biotechnology sector and application of technology, are invaluable to GSK as a pure biopharma company.
Before her current roles, Liz served as Worldwide Vice President and commercial leader in infectious diseases and vaccines and also for immunology and oncology at Janssen Pharmaceuticals, and as Vice President and General Manager at Wyeth Vaccines. Liz was also previously a Board member of Huntsworth Plc and a Board Member and Chair of the Science, Technology and Investment Committee of Bavarian Nordic A/S. Liz has a degree in Engineering and Technical Management and an MBA in Finance.
External Appointments:
- Board Member, BioMarin Pharmaceutical, Inc
- Board Member, Revolution Medicines, Inc
- Board Member, Insmed, Inc
- Trustee, The Wistar Institute
- Director, Aro Biotherapeutics Company, a private company
